GynecologyGynecologyГинекология2079-56962079-5831Consilium Medicum28590ArticlesСтатьиScientific ReportEffect of increased body weight and obesity on the incidence of gynecological pathology, during childbirth, postnatal period and the state of newbornsВлияние повышенной массы тела и ожирения на частоту гинекологической патологии, течение родов, послеродовый период и состояние новорожденныхKarakhalisL YuКарахалисЛ ЮMogilinaM NМогилинаМ НKuban State Medical University of the Ministry of Health of the Russian FederationФГБОУ ВО Кубанский государственный медицинский университет Минздрава России15122016186VOL 18, NO6 (2016)ТОМ 18, №6 (2016)677009042020Copyright ©; 2016, Consilium MedicumCopyright ©; 2016, ООО "Консилиум Медикум"2016Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://gynecology.orscience.ru/2079-5831/article/view/28590

Increased body weight and obesity affect the incidence of gynecological diseases, the development of children, the growth of estrogen-dependent diseases. The issues of prevention of obstetric complications in women with overweight and obesity through the use of modern desogestrel-containing contraceptives.

Повышенная масса тела и ожирение влияют на частоту гинекологической патологии, развитие детей, рост эстрогензависимых заболеваний. Рассмотрены вопросы профилактики послеродовых осложнений у женщин с избыточной массой тела и ожирением посредством применения современных дезогестрелсодержащих контрацептивов.

increased weight and obesitypreventioncontraceptionповышенная масса тела и ожирениепрофилактика заболеваний у детейконтрацепцияПанькив В.И. Ожирение. Междунар. эндокринологический журн. 2013; 5 (53): 28.World Health Organization. Obesity and overweight. Newsletter 2014; 311.Meat consumption providing a surplus energy in modern diet contributes to obesity prevalence: an ecological analysis. BMS Nutrition 2016. DOI: 10.1186/s40795-016-0063-9.Kanagalingam M.G, Forouhi N.G, Greer I.A, Sattar N. Changes in booking body mass index over a decade: retrospective analysis. from a Glasgow Maternity Hospital. Bjog 2005; 112: 1431-3.www.who.int/ru/Engeland A, Bjorge T, Tverdal A, Sogaard A.J. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85.Rittmaster R.S, Deshwal N, Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J Clin Endocrinol Metab 1993; 76: 1295-300.Douchi T, Kuwahata R, Yamamoto S et al. Relationship of upper body obesity to menstrual disorders. Acta Obstet Gynecol Scand 2002; 81: 147-50.Balen A.H, Dresner M, Scott E.M, Drife J.O. Should obese women with polycystic ovary syndrome receive treatment for infertility? (Editorial). Br Med J 2006; 332: 434-5.Farquhar C.M, Gillett W.R. Prioritizing for fertility treatments - should a high BMI exclude treatment? (Commentary). BJOG 2006; 113: 1107-9.Nelson S.M, Fleming R.F. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007; 22: 912-5.Kubo Ai et al. Associations Between Maternal Pregravid Obesity and Gestational Diabetes and the Timing of Pubarche in Daughters. Am J Epidemiol 2016. DOI: 10.1093/aje/kww006.